← FDA DRUG APPROVALS

FDA ANDA · ANDA074556

ACYCLOVIR

Sponsor: TEVA

APPLICATION
ANDA074556
TYPE
ANDA
ORIGINAL APPROVAL
1997-04-22
LATEST ACTION
2009-02-09
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription, Discontinued

Products

ACYCLOVIRPrescription
ACYCLOVIR 800MG · TABLET · ORAL
ACYCLOVIRDiscontinued
ACYCLOVIR 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL
ACYCLOVIRPrescription
ACYCLOVIR 400MG · TABLET · ORAL

Approval history

2009-02-09Labeling · Supplement 19AP
2005-04-20Labeling · Supplement 13AP
2002-01-25Manufacturing (CMC) · Supplement 9AP
2002-01-25Manufacturing (CMC) · Supplement 10AP
2000-08-22Labeling · Supplement 8AP
2000-03-31Manufacturing (CMC) · Supplement 5AP
2000-03-31Manufacturing (CMC) · Supplement 6AP
2000-03-31Manufacturing (CMC) · Supplement 4AP
1998-09-09Labeling · Supplement 3AP
1997-12-16Manufacturing (CMC) · Supplement 2AP
1997-12-16Manufacturing (CMC) · Supplement 1AP
1997-04-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →